Evidence map›Paper›PMID 37959781›Full record

ArticleMolecules (Basel, Switzerland)2023

Aromatic Diboronic Acids as Effective KPC/AmpC Inhibitors.

Joanna Krajewska, Piotr Chyży, Krzysztof Durka, Patrycja Wińska, Krystiana A Krzyśko, Sergiusz Luliński, Agnieszka E Laudy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Joanna KrajewskaDepartment of Pharmaceutical Microbiology and Bioanalysis, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-4963-9521
Piotr ChyżyCentre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-6164-1931
Krzysztof DurkaFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.ORCID 0000-0002-6113-4841
Patrycja WińskaFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.ORCID 0000-0002-2122-1123
Krystiana A KrzyśkoFaculty of Physics, University of Warsaw, 02-093 Warsaw, Poland.ORCID 0000-0003-1687-6851
Sergiusz LulińskiFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.ORCID 0000-0002-9635-5572
Agnieszka E LaudyDepartment of Pharmaceutical Microbiology and Bioanalysis, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-5989-4462
Warsaw University of Technology · PLMedical University of Warsaw · PLUniversity of Warsaw · PL

Funding

Faculty of Physics, University of Warsaw 501-D111-01-1110102 (PP/BF)National Science Centre (Poland) UMO-2018/31/B/ST5/00210POIG POIG.02.01.00-14-122/09
6 · The paper itself

Abstract

Over 30 compounds, including

Indexed as

Anti-Bacterial AgentsCeftazidimeAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesCarbapenemsDrug CombinationsEscherichia coliHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesCarbapenemsCeftazidimeDrug Combinationsantibacterial activityarylboronic acidsKPC/AmpC β-lactamase inhibitorsmolecular dockingtime-dependent QM/MM

Identifiers

PMID37959781
PMCPMC10648349
OpenAlexW4388077753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.